Skip to main content
. 2022 Oct 12;2(10):100192. doi: 10.1016/j.xgen.2022.100192

Table 1.

Lead variants that are protein coding within 26 disease-associated loci identified in the multi-biobank multi-ancestry meta-analyses in GBMI

Endpoint CHR/POS (hg38) REF/ALT Freqa Odds Ratio (95% CI)b p Heterogeneity p Gene Function Cases Controls Number of biobanks
Novel

AAA 10:73913343 T/C 0.737 0.88 (0.85–0.91) 5.93 × 10−12 0.76 PLAU missense 9,453 1,446,422 11
COPD 1:149934520 T/C 0.350 1.04 (1.03–1.05) 7.91 × 10−10 0.54 MTMR11 missense 79,844 1,289,683 15
Stroke 6:49492265 A/G 0.446 0.96 (0.94–0.97) 1.8 × 10−11 0.99 CENPQ missense 60,176 1,310,725 16
Asthma 10:94279840 G/C 0.448 1.03 (1.02–1.03) 2.52 × 10−9 0.98 PLCE1 missense 153,763 1,647,022 18
Asthma 14:100883117 G/T 0.025 1.09 (1.05–1.12) 2.61 × 10−8 0.73 RTL1 missense 133,369 1,370,606 16
Asthma 19:56222056 C/A 0.253 1.03 (1.02–1.04) 2.35 × 10−8 0.60 ZSCAN5A missense 149,293 1,626,581 17

Known

COPD 14:94378610 C/T 0.020 1.22 (1.16–1.29) 5.2 × 10−15 9.27 × 10−3 SERPINA1 missense 54,105 883,399 11
COPD 19:44908684 T/C 0.140 0.95 (0.94–0.97) 1.04 × 10−8 0.36 APOE missense 81,568 1,310,798 16
Gout 2:27508073 T/C 0.588 0.87 (0.86–0.88) 9.27 × 10−64 0.11 GCKR missense 37,105 1,448,128 15
Gout 11:64593747 G/A 0.016 0.36 (0.31–0.42) 1.19 × 10−41 0.10 SLC22A12 stop gain 6,634 248,305 2
Gout 12:57449928 G/A 0.194 0.91 (0.89–0.93) 1.51 × 10−17 0.45 INHBC missense 37,105 1,448,128 15
IPF 5:1279370 T/C 0.001 862 (205–3618) 2.66 × 10−20 0.09 TERT missense 1,278 330,954 2
IPF 5:169588475 G/A 0.014 2.19 (1.81–2.66) 1.61 × 10−15 0.02 SPDL1 missense 4,812 882,416 7
POAG 1:11193760 C/T 0.026 0.67 (0.6–0.74) 4.39 × 10−14 0.90 ANGPTL7 missense 12,810 421,360 5
POAG 1:171636338 G/A 0.002 6.33 (4.71–8.51) 1.67 × 10−34 4.33 × 10−6 MYOC stop gain 15,916 1,092,446 11
POAG 14:60509819 C/A 0.547 0.89 (0.87–0.91) 7.08 × 10−30 0.31 SIX6 missense 26,848 1,460,599 15
Stroke 12:111803962 G/A 0.238 0.9 (0.88–0.92) 5.16 × 10−18 0.37 ALDH2 missense 23,804 269,656 4
VTE 1:169549811 C/T 0.020 3.04 (2.85–3.24) 1.5 × 10−245 5.52 × 10−13 F5 missense 26,749 1,011,509 9
VTE 12:6034818 T/C 0.889 1.1 (1.07–1.13) 1.59 × 10−10 0.21 VWF missense 27,987 1,035,290 9
VTE 12:103742510 C/T 0.011 1.65 (1.45–1.88) 6.19 × 10−14 0.25 STAB2 missense 10,353 341,418 2
Asthma 1:12115601 G/A 0.012 0.85 (0.8–0.89) 1.7 × 10−11 0.46 TNFRSF8 missense 118,767 1,202,660 12
Asthma 1:31699894 G/T 0.573 1.03 (1.02–1.04) 1.61 × 10−10 0.49 COL16A1 missense 148,045 1,579,632 17
Asthma 4:38797027 C/A 0.387 0.95 (0.94–0.96) 4.21 × 10−21 0.54 TLR1 missense 138,764 1,458,022 15
Asthma 4:102267552 C/T 0.044 1.08 (1.06–1.1) 2.53 × 10−12 0.81 SLC39A8 missense 129,434 1,256,670 14
Asthma 5:14610200 C/G 0.084 1.07 (1.05–1.09) 7.68 × 10−15 0.16 OTULINL missense 125,483 1,241,068 13
Asthma 9:128721272 T/A 0.068 0.95 (0.93–0.96) 5.61 × 10−10 0.21 ZDHHC12 missense 152,469 1,638,824 18
a

Frequencies are reported with respect to the alternate allele (ALT) in the combined meta-analysis datasets.

b

Odds ratios are reported with respect to the alternate allele (ALT) in the meta-analyses.